IMI’s RADAR-CNS project has recruited the first participants in the depression component of its study. RADAR-CNS aims to develop new ways of measuring major depressive disorder, epilepsy and multiple sclerosis using wearable devices and smartphone technology. The first study participants have received FitBit Charge 2 devices and smartphone apps.
IMI’s Mofina project has developed a portable device which can test for deadly Ebola in 75 minutes or less, eliminating the need to take suspected Ebola patients to treatment centres far away of their communities. In an interview, the project coordinator explains how Mofina’s success will save lives, and help contain future outbreaks.
The draft topics address the development of tools to aid in the development of treatments for auto-immune diseases; the imaging of immune cells; the use of machine learning in drug discovery; and remote clinical trials.
The incidence of cancer in Europe is increasing but many potential new drug treatments are found to be ineffective when tested on patients. IMI's PREDECT project has investigated new models of tumours to help researchers discover more effective treatments and boost survival rates.
The processes and chemicals used in drug production are often toxic, expensive and produce a lot of waste – posing a threat to the environment and the sustainability of the industry. In response, IMI’s CHEM21 project has developed new manufacturing processes, methods and tools for the pharmaceuticals industry to reduce the use of expensive and toxic materials.
Scientists from IMI’s European Lead Factory (ELF) project have identified novel small molecules that could be transformed into a new medical treatment for depression and pain. The promising compounds will now be further developed by the consortium. The discovery is important as many patients with depression and pain do not respond to current treatments.
New treatments must be tested in clinical trials to ensure they are safe and effective. IMI's EHR4CR project has enabled scientists to find suitable patients by searching millions of medical records while keeping personal data secure.